Safety/Efficacy Study of Retigabine vs. Placebo in Post-Herpetic Neuralgia (PHN)
Public ClinicalTrials.gov record NCT00612105. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Randomized, Double-Blind, Placebo-Controlled, Phase 2a Proof-of-Concept Study to Evaluate the Efficacy of Maximally Tolerated Doses of Retigabine vs. Placebo in Reducing the Pain Associated With Post-Herpetic Neuralgia
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
The purpose of the study is to evaluate the efficacy of retigabine vs. placebo in reducing pain associated with post-herpetic neuralgia.
Study identification
- NCT ID
- NCT00612105
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 2
- Enrollment
- 187 participants
Conditions and interventions
Conditions
Eligibility (public fields only)
- Age range
- 18 Years to 85 Years
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Oct 2007 (Type not available)
- Primary completion
- May 2009 (Actual)
- Completion
- Dec 2009 (Actual)
- Last update posted
- May 8, 2018
2007 – 2009
United States locations
- U.S. sites
- 41
- U.S. states
- 23
- U.S. cities
- 39
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Not listed | Birmingham | Alabama | 35215 | — |
| Not listed | Mesa | Arizona | 85210 | — |
| Not listed | Tucson | Arizona | 85741 | — |
| Not listed | Little Rock | Arkansas | 72205 | — |
| Not listed | Garden Grove | California | 92845 | — |
| Not listed | La Jolla | California | 92037 | — |
| Not listed | San Diego | California | 92128 | — |
| Not listed | Westlake Village | California | 91361 | — |
| Not listed | Orlando | Florida | 32806 | — |
| Not listed | Sarasota | Florida | 34243 | — |
| Not listed | Tampa | Florida | 33613 | — |
| Not listed | West Palm Beach | Florida | 33407 | — |
| Not listed | Atlanta | Georgia | 30308 | — |
| Not listed | Atlanta | Georgia | 30309 | — |
| Not listed | Evansville | Indiana | 47714 | — |
| Not listed | Overland Park | Kansas | 66211 | — |
| Not listed | Lexington | Kentucky | 40503 | — |
| Not listed | Shreveport | Louisiana | 71103 | — |
| Not listed | Bay City | Michigan | 48706 | — |
| Not listed | Detroit | Michigan | 48201 | — |
| Not listed | Hattiesburg | Mississippi | 39401 | — |
| Not listed | St Louis | Missouri | 63117 | — |
| Not listed | St Louis | Missouri | 63141 | — |
| Not listed | Toms River | New Jersey | 8755 | — |
| Not listed | New York | New York | 10004 | — |
| Not listed | Raleigh | North Carolina | 27607 | — |
| Not listed | Tabor City | North Carolina | 28463 | — |
| Not listed | Winston-Salem | North Carolina | 27103 | — |
| Not listed | Fargo | North Dakota | 58104 | — |
| Not listed | Cleveland | Ohio | 44195 | — |
| Not listed | Mogadore | Ohio | 44260 | — |
| Not listed | Allentown | Pennsylvania | 18103 | — |
| Not listed | Bridgeville | Pennsylvania | 15017 | — |
| Not listed | Charleston | South Carolina | 29412 | — |
| Not listed | Little River | South Carolina | 29566 | — |
| Not listed | North Myrtle Beach | South Carolina | 29582 | — |
| Not listed | Nashville | Tennessee | 37215 | — |
| Not listed | Austin | Texas | 78756 | — |
| Not listed | San Antonio | Texas | 78229 | — |
| Not listed | Sugar Land | Texas | 77479 | — |
| Not listed | Midvale | Utah | 84047-1761 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Non-U.S. locations
This page focuses on the U.S. directory. The official record also lists 4 non-U.S. sites.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT00612105, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted May 8, 2018 · Synced Oct 24, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete public registry record, listed eligibility criteria, and available contact information for NCT00612105 live on ClinicalTrials.gov.